Estimated doses to the heart, lungs and oesophagus and risks from typical UK radiotherapy for early breast cancer during 2015-2023
Breast cancer radiotherapy can increase the risks of heart disease, lung cancer and oesophageal cancer. At present, the best dosimetric predictors of these risks are mean doses to the whole heart, lungs and oesophagus, respectively. We aimed to estimate typical doses to these organs and resulting risks from UK breast cancer radiotherapy.
Source: Clinical Oncology - Category: Radiology Authors: Francesca Holt, Addie Ivanova, Zhe Wang, Sarah Darby, Frances Duane, Georgios Ntentas, Sileida Oliveros, Bernadette Lavery, Ketan Shah, Andrew Eichholtz, David Dodwell, Carolyn Taylor (FRCR Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Cardiology | Esophagus Cancer | Heart | Heart Disease | Lung Cancer | Oesophagus | Radiology